HIMS Maintained by Canaccord Genuity -- Price Target Raised to $40
On October 03, 2023, Canaccord Genuity maintained a Buy rating for Hims & Hers Health (HIMS). Analyst Maria Ripps has…
24,080€
1,86%
Echtzeit-Aktienkurs Hims & Hers Health
Bid:
Ask:
Nachrichten zur Hims & Hers Health Aktie
Why is Hims & Hers Health stock rallying today?
Why is Hims & Hers Health stock rallying today?…
Hims & Hers stock rises after Canaccord price target hike
Hims & Hers stock rises after Canaccord price target hike…
HIMS Maintains by B of A Securities -- Price Target Raised to $36
On October 03, 2023, the latest analyst rating for Hims & Hers Health Inc (HIMS) has been released by B…
Hims & Hers Health, Inc. Stock 12?Month Price Target Raised to $29.27, Implies 16% Downside
Explore more price target data and ratings for Hims & Hers Health, Inc. on the Forecasts tab, and track all…
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine…
Canaccord raises Hims and Hers stock price target on weight loss drugs
Canaccord raises Hims and Hers stock price target on weight loss drugs…